Clinical performance of a mid-viscosity artificial tear for dry eye treatment

Cornea

Volumn 26, Issue 3, 2007, Pages 294-302

  Simmons, Peter A ^a   Vehige, Joseph G ^a  

^a ALLERGAN INC   (United States)

Author keywords

Artificial tears; Clinical study; Dry eye; Viscosity

Indexed keywords

ARTIFICIAL TEAR; CARBOXYMETHYLCELLULOSE; EYE DROPS; GENTEAL; HYDROXYPROPYLMETHYLCELLULOSE; REFRESH LIQUIGEL; REFRESH TEAR; REFRESH TEARS; SODIUM CHLORITE; TEARS NATURALE; TETRYZOLINE; UNCLASSIFIED DRUG; VISINE TEARS;

ADULT; AGED; ARTICLE; BLURRED VISION; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EYE DISCHARGE; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAINING; SYMPTOM; TREATMENT DURATION; VISCOSITY; VISUAL DISORDER;

CARBOXYMETHYLCELLULOSE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; METHYLCELLULOSE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; QUESTIONNAIRES; TEARS; VISCOSITY;

EID: 34147142303     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31802e1e04     Document Type: Article

References (15)

1. Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221-232.
2. Pflugfelder SC, Solomon A. Dry eye. In: Holland EJ, Mannis MJ, eds. Ocular Surface Disease. Medical and Surgical Management. New York: Springer-Verlag; 2002:49-57.
3. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621.
4. Food and Drug Administration. Ophthalmic Demulcents. Washington, DC: US Government Printing Office; 2000.
5. Grene RB, Lankston P, Mordaunt J, et al. Unpreserved carboxymethyl- cellulose artificial tears evaluated in patients with keratoconjunctivitis sicca. Cornea. 1992;11:294-301.
6. Meadows DL, Paugh JR, Joshi A, et al. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. Invest Ophthalmol Vis Sci. 2002l;43:1032-1039.
7. Ridder WH III, Sawamura M, Tong J, et al. The effect of artificial tears in the tear layer on contrast sensitivity. Optom Vis Sci. 2001;78(Suppl 12):52.
8. Noecker R. Effects of common ophthalmic preservatives on ocular health. Adv Ther. 2001;18:205-215.
9. Oyejide A, Matsumoto S, Chang J, et al. Comparative ocular histopathological effects of eye drops containing purite(R) (oxychloro complex) or benzalkonium chloride preservatives in rabbits. 2003 ARVO Annual Meeting, Ft. Lauderdale, FL, May 5, 2003, program #1365.
10. TM as a non-disruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives. Invest Ophthalmol Vis Sci. 2001;42:s39.
11. Emory TB, Ousler GW, Abelson MB. All in the blink of an eye. Measuring blink rate and tear film break-up time may help develop new dry eye treatments. Rev Ophthalmol. 2002;9:82-85.
12. Ousler GW, Emory TB, Welch D, et al. Factors that influence the interblink interval (IBI) as measured by the ocular protection index (OPI). 2002 ARVO Annual Meeting, Ft. Lauderdale, FL, May 5, 2002, program #56.
13. Ridder WH III, LaMotte JO, Ngo L, et al. Short-term effects of artificial tears on visual performance in normal subjects. Optom Vis Sci. 2005;82:370-377.
14. Jones LW, Rahman S, Leech R, et al. Determination of tear meniscus height using a novel method based upon optical coherence tomography. 2003 ARVO Annual Meeting, Ft. Lauderdale, FL, May 6, 2003, program #2461.
15. Vehige JG, Carlisle C, Felix C, et al. Clinical trial results of a new emulsion-based dry eye treatment. 2003 ARVO Annual Meeting, Ft. Lauderdale, FL, May 6, 2003, program #2449.